Gender differences in symptoms suggestive of diabetic gastroparesis in the West Bank: clinical insights from a cross-sectional study - Scorecard - MDSpire

Gender differences in symptoms suggestive of diabetic gastroparesis in the West Bank: clinical insights from a cross-sectional study

  • By

  • Diya Asad

  • Qusai Zreqat

  • Shahd T. Idais

  • Marah Hunjul

  • Bara'ah Huseein

  • Alaa Ayyad

  • Hamzeh M. I. Abugharbieh

  • Haroun Neiroukh

  • Areen Zuhour

  • Salsabeel M. Abukhalaf

  • Nour Al-Atrash

  • Roa Alzughayyar

  • Hussein Hallak

  • June 10, 2026

  • 0 min

Share

Clinical Scorecard: Exploring Gender Variations in Diabetic Gastroparesis Symptoms in the West Bank: Insights from a Cross-Sectional Analysis

At a Glance

CategoryDetail
ConditionDiabetic Gastroparesis (DGP)
Key MechanismsAbnormal gastric emptying linked to gender differences, hormonal influences, and neuromuscular dysfunction.
Target PopulationPatients with type 2 diabetes mellitus (T2DM) in the West Bank, Palestine.
Care SettingGovernmental hospitals in Palestine.

Key Highlights

  • DGP prevalence is 4 times higher in females compared to males.
  • Females reported significantly higher severity scores for all gastroparesis symptoms.
  • Logistic regression identified female gender as the only independent factor associated with severe DGP symptoms.
  • GCSI is utilized as a screening tool for assessing DGP symptoms.
  • Poor glycemic control and obesity were more prevalent in female patients.

Guideline-Based Recommendations

Diagnosis

  • Gastroparesis Cardinal Symptom Index (GCSI) is recommended for symptom assessment.

Management

  • Targeted research is needed for gender-based management plans.

Monitoring & Follow-up

  • Monitor glycemic control and symptom severity in patients with DGP.

Risks

  • Increased healthcare burden and morbidity associated with DGP.

Patient & Prescribing Data

Patients with type 2 diabetes mellitus (T2DM) aged 18 years or older.

Management strategies should consider gender differences in symptom prevalence and severity.

Clinical Best Practices

  • Utilize GCSI for symptom assessment in resource-limited settings.
  • Consider hormonal influences when evaluating DGP symptoms in female patients.

Related Resources & Content

Original Source(s)

Related Content